Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
3
×
national blog main
biotech
boston
cancer
clinical trials
abbvie
access biotechnology
access industries
anemia
atlas ventures
blood diseases
blood disorders
brian macdonald
codiak biosciences
crispr
crispr therapeutics
crispr-cas9
cutaneous t-cell lymphoma
disc medicine
drug development
editas
editas medicine
elizabeta nemeth
exosome
fda
financing
incubation
intellia therapeutics
jazz pharmaceuticals
licensing
merganser biotech
national
national top stories
new york blog main
newco
novo nordisk
p53
What
cells
3
×
new
3
×
medicine
red
advance
anemia
based
begin
biosciences
bio’s
blood
body
brings
bubbles
cancer
carry
cas
class
clinical
codiak
crispr
defect
disc
drive
edited
editing
exosome
exosomes
fears
flag
formed
fund
gene
genetic
guardian
having
health
human
ipo
iron
Language
unset
Current search:
cells
×
new
×
" life sciences "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells